| Name: | Azacitidine Related Compound B |
| Catalogue No. | VL4540003 |
| CAS No. | 6974-32-9 |
| Molecular Formula | C28H24O9 |
| Molecular Weight | 504.48 |
| Status | In-stock |
| IUPAC Name | 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribose |
| Appearance | white to light yellow crystal powder |
| Description | Azacitidine Related Compound B (CAS No: 6974-32-9) or 1-O-Acetyl-2,3,5-tri-O-benzoyl-β-D-ribose, cytosine nucleoside and belongs to the antineoplastic class used in DNA and RNA. it is used in the treatment of acute myeloid leukemia |
| References | Pleyer, Lisa, et al. “Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.” International Journal of Molecular Sciences, vol. 18, no. 2, 15 Feb. 2017, p. 415, www.ncbi.nlm.nih.gov/pmc/articles/PMC5343949/, 10.3390/ijms18020415. Accessed 28 Jan. 2022. |
